logo

For the Inventor, By the Inventor

Pacifica, CA, United States of America

Mark S Stanley

This inventor holds 16 USPTO granted patents and 10 published patent applications and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Genentech, Inc., Curis, Inc., F. Hoffmann-La Roche Ag. Active years: 1998-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark S Stanley. Retrieved from https://idiyas.com/inventor/mark-s-stanley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 56.3

 

Average Co-Inventor Count = 7.2

ph-index = 6

Forward Citations = 143(Granted Patents)


Company Filing History:

goldMedal13 out of 3,302 
 
Genentech, Inc.
 patents
silverMedal3 out of 141 
 
Curis, Inc.
 patents
bronzeMedal1 out of 181 
 
F. Hoffmann-La Roche Ag
 patents
4. 1 out of 16,048 
 
University of California
 patents
where one patent can have more than one assignee

Years Active: 1998-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Pyridyl Inhibitors
Hedgehog Signalling
Janus Kinase Inhibitors
Aza-Benzothiophenyl Compounds
Integrin Receptor Inhibitors
LFA-1 Antagonists
Peptidomimetic Compounds
Growth Hormone Secretagogues
CNS Disorders
Low Molecular Weight
Compounds and Methods
Transport Inhibition
16 patents (USPTO):Explore Patents
1. 9790183 - Pyridyl inhibitors of hedgehog signalling (2017-10-17),
2. 9321761 - Pyridyl inhibitors of hedgehog signalling (2016-04-26),
3. 9278961 - Pyridyl inhibitors of hedgehog signalling (2016-03-08),
4. 8486950 - Janus kinase inhibitor compounds and methods (2013-07-16),
5. 7893085 - Aza-benzothiophenyl compounds and methods of use (2011-02-22),
6. 7888364 - Pyridyl inhibitors of hedgehog signalling (2011-02-15),
7. 7855216 - Aza-indolyl compounds and methods of use (2010-12-21),
8. 7265146 - Integrin receptor inhibitors (2007-09-04),
9. 7094869 - Low molecular weight peptidomimetic growth hormone secretagogues (2006-08-22),
10. 6933314 - Integrin receptor inhibitors (2005-08-23),
11. 6872735 - LFA-1 antagonist compounds (2005-03-29),
12. 6706753 - Integrin receptor inhibitors (2004-03-16),
13. 6667318 - LFA-1 antagonist compounds (2003-12-23),
14. 6034216 - Low molecular weight peptidomimetic growth hormone secretagogues (2000-03-07),
15. 5942537 - Method of inhibiting the transport of L-glutamate to treat CNS disorders (1999-08-24),

Title: The Innovative Journey of Mark S Stanley

Introduction: Mark S Stanley, a talented inventor hailing from Pacifica, CA (US), has made significant contributions to the world of innovation with his creative mind and dedication to progress.

Latest Patents: Mark S Stanley's latest patents include cutting-edge technologies in the field of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to shaping a better future for generations to come.

Career Highlights: Throughout his illustrious career, Mark S Stanley has been recognized for his groundbreaking inventions that have revolutionized various industries. His ability to think outside the box and solve complex problems has led to the development of products that have improved efficiency and sustainability.

Collaborations: Mark S Stanley has collaborated with leading research institutions, universities, and companies to bring his ideas to life. His partnerships have been instrumental in turning his innovative concepts into tangible solutions that have had a positive impact on society.

Conclusion: In conclusion, Mark S Stanley's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His remarkable contributions continue to inspire others to push the boundaries of what is possible and create a better world through innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…